Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
03/2000
03/30/2000WO2000017190A2 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
03/30/2000WO2000016814A1 Medicinal aerosol formulation
03/30/2000WO2000016783A1 Method of preventing acute lung injury
03/30/2000WO2000016745A2 Micronised pharmaceutical compositions
03/30/2000WO1999065449A3 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB
03/30/2000WO1999063931A9 Peptidyl-prolyl cis-trans isomerase inhibitors and uses therefor
03/30/2000WO1998053846A9 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
03/30/2000CA2344657A1 Human isre-binding protein
03/30/2000CA2344262A1 4-aminopyrrolopyrimidines as kinase inhibitors
03/30/2000CA2344249A1 Pyrrolopyrimidines as protein kinase inhibitors
03/30/2000CA2344224A1 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
03/30/2000CA2344223A1 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
03/30/2000CA2344100A1 31 human secreted proteins
03/30/2000CA2343360A1 Human cytoskeleton associated proteins
03/30/2000CA2343353A1 Methods and compositions relating to egf-repeat-containing polypeptides
03/30/2000CA2341241A1 Method of preventing acute lung injury
03/29/2000EP0988861A1 Stabilized protein compositions
03/29/2000EP0988377A1 Zinc finger protein derivatives and methods therefor
03/29/2000EP0988301A1 Imidazolyl-cyclic acetals
03/29/2000EP0988298A1 Coumarin derivatives, methods of preparation and application as medicines
03/29/2000EP0801554A4 Formulations and methods for reducing skin irritation
03/29/2000EP0726763B1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
03/29/2000CN1248966A Aminobenzophenones as inhibitors of interleukin and TNF
03/29/2000CN1050840C 咪唑脂氧合酶抑制剂 Imidazole lipoxygenase inhibitors
03/29/2000CN1050839C Sulfonylamino pyrimidines compounds, medicinal composition containing same, its preparation process and use
03/28/2000US6043265 Isoxazolyl endothelin antagonists
03/28/2000US6043263 (2,3-dihydrobenzofuranyl)-thiazoles as phosphodiesterase inhibitors
03/28/2000US6043250 Treating or preventing inflammatory diseases
03/28/2000US6043239 Heterocyclic compounds
03/28/2000US6043054 Polynucleotides encoding a novel GABA BP polypeptide
03/23/2000WO2000015802A1 Moraxella catarrhalis basb034 polypeptides and uses thereof
03/23/2000WO2000015797A2 Compositions and methods for the treatment of immune related diseases
03/23/2000WO2000015793A2 Human gpcr proteins
03/23/2000WO2000015775A1 Rnase p polypeptides
03/23/2000WO2000015770A2 Human serine/threonine protein kinases
03/23/2000WO2000015639A1 Carboline derivatives as cgmp phosphodiesterase inhibitors
03/23/2000WO2000015614A1 Novel compounds
03/23/2000WO2000015612A1 Aza-bicycles which modulate the inhibition of cell adhesion
03/23/2000WO2000015609A1 Azetidine derivatives, preparation and medicines containing them
03/23/2000WO2000015246A2 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto
03/23/2000WO2000015245A2 Stable liquid formulations of botulinum toxin
03/23/2000WO2000015234A1 Compositions comprising corticosteroids for treating sinusitis or otitis media
03/23/2000WO2000015228A1 Combinations of tetracyclic cyclic gmp-specific phosphodiesterase inhibitors with further therapeutic agents
03/23/2000WO2000015226A1 Antihistamines for treating non-infective sinusitis or otitis media
03/23/2000WO2000015198A1 Orally administered controlled drug delivery system providing temporal and spatial control
03/23/2000WO1999063983A9 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
03/23/2000CA2343760A1 Orally administered controlled drug delivery system providing temporal and spatial control
03/23/2000CA2343578A1 Human serine/threonine protein kinases
03/23/2000CA2342833A1 Human gpcr proteins
03/23/2000CA2342398A1 Moraxella catarrhalis basb034 polypeptides and uses thereof
03/23/2000CA2342243A1 Stable liquid formulations of botulinum toxin
03/23/2000CA2341683A1 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto
03/23/2000CA2341677A1 Aza-bicycles which modulate the inhibition of cell adhesion
03/23/2000CA2341440A1 Novel compounds
03/22/2000EP0987552A2 Diarylsulfonylurea binding proteins
03/22/2000EP0987269A1 Salts of optically active sulfoxide derivative
03/22/2000EP0987256A1 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamid
03/22/2000EP0986530A1 Indane compounds and their pharmaceutical use
03/22/2000CN1248259A Condensed pyridazing derivatives, their production and use
03/22/2000CN1248169A Compositions for treatment of ARDS or IRDS containing 3-(cyclopropylmethoxy)-N-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy) benzamide and lung surfactant
03/22/2000CN1050514C Antiallergic composition for ophthalmic or nasal use
03/21/2000US6040451 Used as analgesic, sedative and anaesthetic agents
03/21/2000US6040447 Reacting a halogenated amino pyrimidine compound with acid anhydride or acid halide to form an intermediate, transforming the 6-halo group of the intermediate to an amine by displacement with ammonia, cyclizing with a base
03/21/2000US6040344 Crystalline r,r-formoterol l-(+)-tartrate.
03/21/2000US6040329 Substituted indazole analogs
03/21/2000US6040328 Aromatic diselenides and selenosulfides, their preparation and their uses, more particularly their therapeutical use
03/21/2000US6040310 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide Y receptor antagonists
03/21/2000US6040309 Benzothiophene derivatives useful in therapy
03/21/2000US6040296 Specific antisense oligonucleotide composition & method for treatment of disorders associated with bronchoconstriction and lung inflammation
03/21/2000US6040162 Amino acid sequence which couples histidine to transfer rna; for screening bacteriostats and bactericides
03/21/2000US6040133 D-enzyme compositions and methods of their use
03/21/2000US6039974 Drugs of multilayer tablets
03/21/2000US6039969 Immune response modifier compounds for treatment of TH2 mediated and related diseases
03/21/2000CA2146097C 1h-indole-3-glyoxylamide spla2 inhibitors
03/16/2000WO2000014235A1 Kunitz domain polypeptide zkun6
03/16/2000WO2000014222A2 GABAB RECEPTOR SUBTYPES GABAB-R1c AND GABAB-R2 AND HETERODIMERS THEREOF
03/16/2000WO2000014097A2 Novel pyranoses
03/16/2000WO2000014086A1 Chemokine receptor antagonists and methods of use therefor
03/16/2000WO2000014083A1 SUBSTITUTED η-PHENYL-Δ-LACTONES AND ANALOGS THEREOF AND USES RELATED THERETO
03/16/2000WO2000014066A1 4,4-biarylpiperidine derivatives with opioid receptor activity
03/16/2000WO2000013703A2 Methods of treating hypertension and compositions for use therein
03/16/2000WO2000013702A2 Use of an angiogenic factor for the treatment of microvascular angiopathies
03/16/2000WO2000013685A1 Treating inflammatory diseases of the head and neck with cyclooxygenase-2 inhibitors
03/16/2000WO2000006694A3 Compound and method for the prevention and/or the treatment of allergy
03/16/2000WO2000000209A3 Use of iso-osmotic saline solutions, method for preparing same and medicine based on said solutions
03/16/2000WO1999066912A3 Method of treating pulmonary hypertension
03/16/2000WO1999061471A3 Human transmembrane proteins
03/16/2000CA2342882A1 Chemokine receptor antagonists and methods of use therefor
03/16/2000CA2342855A1 Novel pyranoses
03/15/2000EP0985149A1 Methods for evaluating tissue morphogenesis and activity
03/15/2000EP0984981A1 Anti-inflammatory tyrosine derivatives
03/15/2000EP0984966A1 9-AZABICYCLO(3.3.1)NON-2-ENE AND NONANE DERIVATIVES AS CHOLINERGIC LIGANDS AT NICOTINIC ACh RECEPTORS
03/15/2000EP0984965A1 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors
03/15/2000EP0984963A1 Novel compounds
03/15/2000EP0984961A1 Novel pyridine derivatives and pharmaceutical compositions containing them
03/15/2000EP0984784A2 Anti-cancer products for treating cystic fibrosis
03/15/2000EP0984778A1 Neuropeptide-y ligands
03/15/2000EP0850232B1 Benzothiazolone derivatives
03/15/2000EP0567566B1 Methods for treating tumor necrosis factor mediated diseases
03/15/2000CN1247533A Heterocyclic carboxylic acid derivatives, prodn. and use thereof as endothelin receptor antagonists
1 ... 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 ... 878